On 14 MAY Plug Power Inc (NASDAQ:PLUG) release its earnings for the first quarter of its fiscal 2014 (1QFY14, ended March 31, 20 Revenues for the quarter beat consensus estimates but declined on a yearly basis due to lower shipments. Quarterly revenues clocked in at $5.57 million, declining 13.6% year-over-year (YoY) but trumping analysts’ expectations of $5.35 million by 4.2%. The Latham, New York based-company has performed below analysts’ expectations with regard to revenues just once in the past five quarters. Plug Power Inc (NASDAQ:PLUG) weekly performance is 6.70%. On last trading day company shares ended up $4.30. Analysts mean target price for the company is $4.88. Plug Power Inc (NASDAQ:PLUG) distance from 50-day simple moving average (SMA50) is -27.11%.
Yahoo! Inc. (NASDAQ:YHOO) is in discussions to acquire RayV Inc., a startup that specializes in enhancing high-definition online video streaming. Yahoo! Inc. (NASDAQ:YHOO) shares advanced 0.99% in last trading session and ended the day on $34.70. YHOO Gross Margin is 71.50% and its return on assets is 8.00%. Yahoo! Inc. (NASDAQ:YHOO) quarterly performance is -6.95%.
Sirius XM Holdings Inc. (NASDAQ:SIRI) will broadcast the 2014 NCAA® Division I Men’s Lacrosse Semifinals and National Championship game live from M&T Bank Stadium in Baltimore, MD, this Saturday, May 24, and Monday, May 26.Sirius XM Holdings Inc. (NASDAQ:SIRI) shares moved up 3.15% in last trading session and was closed at $3.27, while trading in range of $3.17 – $3.28. Sirius XM Holdings Inc. (NASDAQ:SIRI) year to date (YTD) performance is -6.30%.
Groupon Inc (NASDAQ:GRPN) is currently the target of a fierce boycott effort by the animal-rights group PETA, which says Groupon “promotes cruelty to animals” by offering deals for zoos and circuses. Groupon Inc (NASDAQ:GRPN) ended the last trading day at $5.98. Company weekly volatility is calculated as 3.17% and price to cash ratio as 3.93. Groupon Inc (NASDAQ:GRPN) showed a negative weekly performance of -1.16%.
On 14 MAY MannKind Corporation (NASDAQ:MNKD) has developed a product called AFREZZA for the delivery of insulin in Type 1 and Type 2 diabetic patients. The simplistic description of AFREZZA is that it’s an insulin inhaler that could render insulin injections obsolete in the future. MannKind Corporation (NASDAQ:MNKD) weekly performance is 11.98%. On last trading day company shares ended up $7.76. Analysts mean target price for the company is $8.07. MannKind Corporation (NASDAQ:MNKD) distance from 50-day simple moving average (SMA50) is 24.55%.
Leave a Reply